NSE · KIMS
Krishna Institute of Medical Sciences Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹484 Cr with net profit ₹67 Cr — a 13.75% net margin, versus 14.45% the period before.
Shareholding
As of 2026-06-30
- Promoter32.5%
- Public18.33%
- FII14.74%
- DII34.43%
94,730 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.49× from low to high.
Risk flags
Derived from disclosed data
- Promoter holding fell 1.61 percentage points to 32.5% in the latest disclosure.
Peer comparison
Healthcare · ranked #8 of 85 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,30,398 Cr | 61.98 | 13.75 | 20.48% | 7.91% |
| Max Healthcare Institute Ltd. | ₹1,03,161 Cr | 68.91 | 9.6 | 13.42% | 16.73% |
| Manipal Health Enterpri Limited | ₹1,00,094 Cr | 106.73 | 6.09 | 10.59% | 7.81% |
| Fortis Healthcare Ltd. | ₹67,493 Cr | 63.27 | 6.82 | 10.53% | 11.02% |
| Aster DM Quality Care Ltd. | ₹66,295 Cr | 170.91 | 15.76 | 8.48% | 6.54% |
| Global Health Limited | ₹40,226 Cr | 70.27 | 10.15 | 14.05% | 11.88% |
| Narayana Hrudayalaya Ltd. | ₹39,223 Cr | 45.5 | 8.64 | 17.76% | 9% |
| Krishna Institute of Medical Sciences Ltd.(this company) | ₹33,519 Cr | 160.57 | 8.94 | 10.74% | 4.85% |
| Dr. Lal Path Labs Ltd. | ₹32,299 Cr | 57.42 | 12.88 | 20.13% | 18.75% |
| Poly Medicure Ltd. | ₹17,504 Cr | 54.7 | 5.64 | 10.37% | 15.77% |
AI analysis
AI-generated · google/gemini-2.5-flashKrishna Institute of Medical Sciences Ltd. has a market capitalization of Rs 33122 Cr. The company's revenue stands at Rs 3067 Cr, with revenue growth reported at 21.5%. It has a profit margin of 6.18% and a debt-to-equity ratio of 0.99.
Positives
- +Revenue grew 21.5% to Rs 3067 Cr.
- +Debt-to-equity ratio is 0.99.
- +Institutional shareholding is 49.17% as of June 30, 2026.
Negatives
- −The trailing twelve-month PE ratio is 743.96, which is high.
- −Net profit declined from Rs 101.8 Cr in Mar 2025 to Rs 42.5 Cr in Mar 2026.
- −Promoter holding decreased from 38.84% in Mar 2023 to 32.50% in Jun 2026.
- −Promoter pledge stands at 10.26% of promoter holding.
Financial Performance
The company reported annual revenue of Rs 3067 Cr, demonstrating a growth of 21.5%. Profit margin for the company is 6.18%. Over recent quarters, revenue has increased from Rs 772.4 Cr in Dec 2024 to Rs 1074.6 Cr in Mar 2026. However, net profit has seen a decline from Rs 101.8 Cr in Mar 2025 to Rs 42.5 Cr in Mar 2026.
Profitability & Returns
Krishna Institute of Medical Sciences Ltd. has a Return on Equity (ROE) of 10.74% and a Return on Capital Employed (ROCE) of 7.99%. The earnings per share (EPS) are Rs 5.91. The company's profit margin is 6.18%, indicating the percentage of revenue translated into profit.
Balance Sheet
The company maintains a debt-to-equity ratio of 0.99. The book value per share is Rs 89.22. No dividend yield was reported for the company.
Ownership & Pledges
Public shareholding is 18.33%. Promoter pledge stands at 10.26% of the promoter holding. The number of shareholders is 94730.
Shareholding Trend
Promoter holding has decreased from 38.84% in June 2021 to 32.50% in June 2026. During the same period, FII holding has fluctuated, currently at 14.74% as of June 2026, down from 19.40% in March 2023. DII holding has generally increased, reaching 34.43% in June 2026 from 13.81% in June 2021. Public shareholding has increased from 11.99% in March 2023 to 18.33% in June 2026. Promoter pledged shares, held by Bhaskara Rao Bollineni, constituted 13.32% of shares held by promoter and promoter group as of March 31, 2026.
Data as of — price: 2026-09-23 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Krishna Institute of Medical Sciences Ltd.share price & fundamentals